EPISODE · Jan 15, 2016 · 33 MIN
Does Nintedanib Benefit Certain Subgroups of IPF Patients More than Others? An Analysis of the Data from the INPULSIS Trials
from Out of the Blue: An AJRCCM Podcast · host American Thoracic Society
Dr. Nitin Seam talks with Drs. Ulrich Costabel and Athol Wells about idiopathic pulmonary fibrosis and which patients may benefit from nintedanib treatment. They discuss the INPULSIS trials and Dr. Costabel's article in the January 15 issue of AJRCCM.
Embed this episode
NOW PLAYING
Does Nintedanib Benefit Certain Subgroups of IPF Patients More than Others? An Analysis of the Data from the INPULSIS Trials
0:00
33:10
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Out of the Blue: An AJRCCM Podcast?
This episode is 33 minutes long.
When was this Out of the Blue: An AJRCCM Podcast episode published?
This episode was published on January 15, 2016.
Can I download this Out of the Blue: An AJRCCM Podcast episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!